Evidence map›Paper›PMID 42464353›Full record

ArticleAlzheimer's research & therapy2026

Resting-state functional dynamics alterations relate to plasma amyloid markers and statistically explain memory impairments in the TgF344-AD model of Alzheimer's disease.

Alya Al-Awlaqi, Lori Berckmans, Sam De Waegenaere, Sarah Vanherle, Joseph Griffis, Ilse Dewachter, Marleen Verhoye, Mohit H Adhikari

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alya Al-Awlaqi *Bio-Imaging Lab, University of Antwerp, Building UC, Campus Drie Eiken, Universiteitsplein 1, Wilrijk, Antwerp, 2610, Belgium.
Lori Berckmans *Bio-Imaging Lab, University of Antwerp, Building UC, Campus Drie Eiken, Universiteitsplein 1, Wilrijk, Antwerp, 2610, Belgium.
Sam De Waegenaere *Bio-Imaging Lab, University of Antwerp, Building UC, Campus Drie Eiken, Universiteitsplein 1, Wilrijk, Antwerp, 2610, Belgium.
Sarah VanherleBiomedical Research Institute, Department of Neuroscience, Faculty of Medicine and Life Sciences, University of Hasselt, Hasselt, Belgium.
Joseph GriffisNeuroimaging and Noninvasive Brain Stimulation Lab, University of Iowa, Iowa City, USA.
Ilse DewachterBiomedical Research Institute, Department of Neuroscience, Faculty of Medicine and Life Sciences, University of Hasselt, Hasselt, Belgium.
Marleen Verhoye *Bio-Imaging Lab, University of Antwerp, Building UC, Campus Drie Eiken, Universiteitsplein 1, Wilrijk, Antwerp, 2610, Belgium.
Mohit H Adhikari *Bio-Imaging Lab, University of Antwerp, Building UC, Campus Drie Eiken, Universiteitsplein 1, Wilrijk, Antwerp, 2610, Belgium. mohit.adhikari@uantwerpen.be.ORCID http://orcid.org/0000-0002-3404-8307

Funding

Bijzonder Onderzoeksfonds UAntwerp 50751Fonds Wetenschappelijk Onderzoek G045420NInternationale Stichting Alzheimer Onderzoek SAO-FRA 2020/027
6 · The paper itself

Abstract

backgroundResting-state functional MRI studies of Alzheimer's disease (AD) show lower functional connectivity (FC) of AD-relevant regions and resting-state networks in patients and transgenic rodent models at symptomatic stages. However, at early stages of the disease, both hyper and hypo connectivity has been reported. Traditional FC overlooks temporal fluctuations in connectivity and network dynamics at a short timescale captured by transient brain states such as co-activation patterns (CAPs). CAPs have been shown to be more sensitive than FC to detect early alterations in neurodegenerative diseases and therefore can shed light on hyper versus hypo connectivity observed at early stages. Moreover, how brain functional signatures of Alzheimer's disease are related to its behavioral and pathological markers and whether they have prognostic relevance remain scarcely investigated.

methodsWe acquired high temporal resolution resting-state functional MRI data in the TgF344-AD model rats and age-matched wild-type animals at 4 and 10 months of age corresponding to the pre-plaque and plaque stages, respectively and delineated brain functional alterations using FC and CAPs in the model animals. We also assessed the levels of amyloid beta (Aβ) in blood and working and reference memory performance in the same animals at the plaque stage and investigated their statistical relationship with pre-plaque and plaque-stage changes in FC and CAPs.

resultsTgF344-AD rats had significantly elevated blood Aβ levels, committed more working and reference memory errors and showed reduced hippocampal FC with the lateral cortical and default-mode-like network compared to wild-type animals at the plaque stage. FC at the pre-plaque stage did not differ between TgF344-AD and wild-type rats. TgF344-AD rats showed hyper- and hypo-activation in the default-mode-like-network and hippocampal regions at pre-plaque and plaque stages, respectively, in multiple CAPs. Blood Aβ levels were statistically explained more accurately by plaque-stage, than pre-plaque stage, FC values and CAP activations. CAP activations, especially at the pre-plaque stage, outperformed FC in accurate statistical explanation of memory impairments.

conclusionOur findings demonstrate pre-plaque stage hyperconnectivity not in the traditional, static measure of functional connectivity but in transient, dynamic brain states and that these early brain functional signatures have prognostic relevance for memory deficits in a translational rat model of Alzheimer's disease.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBrainMemory DisordersAnimalsBiomarkersDisease Models, AnimalMagnetic Resonance ImagingMaleRatsRats, Inbred F344Rats, TransgenicRestAmyloid beta-PeptidesBiomarkersBlood-plasma markersCo-activation patternsFunctional MRIPartial-least-squares regression.Resting-stateWorking memory

Identifiers

PMID42464353
PMCPMC13656584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.